XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
SCENDIA PURCHASE AGREEMENT (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Apr. 01, 2023
Aug. 31, 2023
Jul. 31, 2022
Dec. 31, 2022
Merger agreement cash consideration $ 16,792,037      
Cash consideration     $ 10,000,000.0  
Number of shares     486,145  
Earnout payment   $ 693,000    
Scendia Acquisition [Member]        
Acquisition costs       $ 187,000
Purchase Agreement [Member]        
Issuance of common stock for purchase of assets     291,686  
Number of shares issued     94,798  
Proceeds from offering     $ 1,950,000  
Purchase Agreement [Member] | Scendia Biologics LLC [Member]        
Merger agreement cash consideration     $ 1,600,000  
Scendia Biologics LLC [Member]        
Equity method ownership percentage     50.00%  
Membership Interest Purchase Agreement [Member]        
Equity method ownership percentage     100.00%  
Scendia Biologics LLC [Member] | Scendia Purchase Agreement [Member]        
Equity method ownership percentage     100.00%